
EVERSANA
Founded Year
2018Stage
Other Investors | AliveAbout EVERSANA
EVERSANA provides services to the life sciences industry. The company offers integrated solutions that are based on the patient experience and cover various stages of the product life cycle. EVERSANA serves the life sciences sector, including pharmaceutical companies and healthcare organizations. It was founded in 2018 and is based in Milwaukee, Wisconsin.
Loading...
Loading...
Expert Collections containing EVERSANA
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
EVERSANA is included in 1 Expert Collection, including Conference Exhibitors.
Conference Exhibitors
5,302 items
Latest EVERSANA News
Nov 13, 2025
AMHERST, NH, UNITED STATES, November 13, 2025 / EINPresswire.com / -- When the heart stumbles, the world often stops with it. But for Jim Kaveney , a serial entrepreneur and learning pioneer, the irregular beat that almost derailed his life became the rhythm of his purpose. Over a decade ago, Jim was building one of the most dynamic learning and performance companies in the United States. His vision was to bridge a gap that few others had seen: the space between what people know and what they believe. In the healthcare sector, he observed that while professionals were trained for precision, they were rarely trained for mindset the quiet discipline that turns knowledge into compassionate action. That vision became Alkemy Partners, a firm that combined behavioural science, training design, and performance psychology to build better leaders and better teams across healthcare. Within years, Alkemy's growth was meteoric. Twice ranked among America's fastest-growing private companies on the Inc. 5000 list, Alkemy became a trusted partner to pharmaceutical and healthcare giants alike. In 2020, EVERSANA, a global leader in life sciences services, acquired Alkemy to scale its impact worldwide. Jim stayed on as Vice President of Training Solutions, shaping global learning programmes designed to maximise not just performance, but human potential. But while the company soared, Jim's body began to rebel. He noticed his heart beating irregularly, faster, then slower, then out of sync entirely. Weeks of testing led to a diagnosis that would alter the course of his life: Atrial Fibrillation (AFib), a condition where the heart's rhythm becomes chaotic and unpredictable. “I remember lying in a hospital bed thinking, I've built companies, strategies, and systems but I've never built peace with my own body,” he recalls. “That was the start of a different kind of journey.” For many, AFib brings fear a sense of limitation, an invisible countdown. But Jim, the educator, saw a pattern: what if the way we think about diagnosis is part of the problem? What if the management of illness isn't just about medication, but about meaning? That question became the foundation of his next venture Unlimited Heart , a global initiative designed to help patients, caregivers, and clinicians reframe the experience of living with AFib. Unlimited Heart's mission is disarmingly simple and profoundly human: to help people with AFib see their diagnosis as a turning point rather than a terminus. The organisation brings together leading cardiologists, psychologists, wellness specialists, and patient advocates to tackle one of the most under-addressed challenges in chronic health management Lifestyle Modification. “Medicine can stabilise your condition,” Jim says, “but mindset sustains your recovery. If we can build better people, we can build better patients.” Unlimited Heart provides learning programmes, patient education initiatives, and partnership opportunities with hospitals and research foundations. Its frameworks focus on the emotional, behavioural, and psychological dimensions of heart health, stress, sleep, diet, movement, and mindset, the very things that define whether medical treatment succeeds or fails over time. The model is built on the same principles that once made Alkemy Partners a leader in corporate learning: measurable performance improvement, individual accountability, and a human-centred approach to growth. But here, the metrics are different, quality of life, confidence, and resilience. Jim's personal experience with AF became the test case. “There's a strange humility that comes with hearing your heart misfire,” he says. “It's a reminder that no spreadsheet, no company, no achievement matters if you're disconnected from yourself. Unlimited Heart is about restoring that connection, between body, mind, and purpose.” In the coming year, Unlimited Heart plans to launch a series of pilot programmes in partnership with healthcare organisations, focusing on patient education and post-diagnosis mindset support. Discussions are also underway with medical researchers to measure the impact of behavioural change on AF outcomes. While the science is essential, Jim insists that the heart of this mission is empathy. “We talk endlessly about innovation in healthcare,” he reflects, “but the most radical innovation might simply be remembering that the patient is human, frightened, hopeful, capable of transformation. “I believe that every"body" can become a center of excellence.” Unlimited Heart aims to make that humanity teachable. Because sometimes, the next medical revolution doesn't begin in a laboratory. It begins in the silence between heartbeats, when someone decides that what once broke them will now define what they build. About Unlimited Heart Founded by entrepreneur and learning innovator Jim, Unlimited Heart is a global initiative uniting science, psychology, and storytelling to help people live fuller lives with Atrial Fibrillation (AF). Drawing on Jim's experience in behavioural learning, entrepreneurship, and his personal AF journey, Unlimited Heart offers mindset-based wellness and lifestyle programmes that complement medical treatment. Its guiding belief: If we can build Better People, we can build Better Patients. Alfie Brown A-B MEDIA 7876586946 ext. email us here Visit us on social media: LinkedIn Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
EVERSANA Frequently Asked Questions (FAQ)
When was EVERSANA founded?
EVERSANA was founded in 2018.
Where is EVERSANA's headquarters?
EVERSANA's headquarters is located at 190 North Milwaukee Street, Milwaukee.
What is EVERSANA's latest funding round?
EVERSANA's latest funding round is Other Investors.
Who are the investors of EVERSANA?
Investors of EVERSANA include Water Street Healthcare Partners, JLL Partners, North Sky Capital and Revelation Partners.
Who are EVERSANA's competitors?
Competitors of EVERSANA include Axtria, Amboss, Future Cardia, MedShr, Trinity Life Sciences and 7 more.
Loading...
Compare EVERSANA to Competitors
PSL Group focuses on providing research and information solutions within the healthcare industry. The company offers market research services, including testing and tracking, to assist pharmaceutical and biotechnology companies with branding strategies and marketing initiatives. PSL Group also provides online fieldwork services for conducting Internet-based market research with various types of physicians. It was founded in 2015 and is based in New York, New York.
TriApex is a contract research organization (CRO) focused on enabling drug research and development (R&D) for pharmaceutical enterprises and research institutions, with an emphasis on disease-oriented solutions. The company offers a range of services, including nonclinical research, clinical research, translational research, regulatory strategies, safety assessments, and laboratory services to support the drug development process. TriApex serves the pharmaceutical and research sectors, providing R&D services in ophthalmology, central nervous system (CNS) diseases, and metabolic diseases. TriApex was formerly known as Tripod Preclinical Research Laboratories. It was founded in 2008 and is based in Nanjing, China.

Medidata specializes in providing a unified platform for clinical research within the life sciences sector. The company offers a range of products and solutions designed to streamline clinical trials, including data management, clinical operations, and patient engagement technologies. Medidata's platform serves various sectors, including biopharmacy, medical device companies, and academic research organizations. It was founded in 1999 and is based in New York, New York.

Trinity Life Sciences specializes in life sciences commercialization and analytics services. The company provides services including planning, market access, pricing, launch, and brand optimization, using data and artificial intelligence for decision-making. Trinity Life Sciences mainly serves the pharmaceutical, biotech, and medical device sectors. It was founded in 1996 and is based in Waltham, Massachusetts.

Syneos Health operates as a biopharmaceutical solutions organization focused on providing services in the biopharmaceutical industry. The company offers services including clinical development, regulatory affairs, commercialization, marketing, patient recruitment for clinical trials, and healthcare business intelligence. Syneos Health primarily serves the biopharmaceutical sector, supplying insights and technologies. Syneos Health was formerly known as INC Research Holdings. It was founded in 1998 and is based in Morrisville, North Carolina.
MedaSystems delivers a comprehensive platform for managing requests for investigational therapies. Its GxP‑compliant SaaS solution unifies Expanded Access, Post‑Trial Access, and Investigator‑Initiated Study workflows in a single workspace that seamlessly connects physicians with biopharma sponsors worldwide. MedaSystems automates inquiry intake, real‑time tracking, and regulatory‑ready data capture to remove administrative bottlenecks and foster collaboration between clinicians and life‑science teams. MedaSystems serves the enterprise, biotech, and contract research organization sectors within the life sciences domain. It was founded in 2021 and is based in Menlo Park, California.
Loading...